Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Limonene synthase is a key plant enzyme responsible for the biosynthesis of the monoterpene limonene from geranyl pyrophosphate (GPP). This enzyme exists in two enantiomeric forms: (S)-limonene synthase (EC 4.2.3.16), which produces (-)-limonene found in peppermint and spearmint, and (R)-limonene synthase (EC 4.2.3.20), which produces (+)-limonene characteristic of citrus fruits. Biologically, the enzyme plays a crucial role in plant defense mechanisms, producing volatile compounds that can deter herbivores or attract pollinators. While limonene itself is studied for potential anticancer and anti-inflammatory properties, the enzyme is not a recognized therapeutic target in human disease. Instead, it is a major focus in metabolic engineering and synthetic biology for the industrial production of limonene, which is used extensively in fragrances, flavoring agents, and as a renewable solvent or biofuel precursor (Croteau et al., 1987; UniProt P14714).
Catalyzes the cyclization of geranyl pyrophosphate (GPP) into limonene through a carbocation-mediated mechanism involving the loss of a pyrophosphate group and subsequent ring closure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Limonene synthase (LS).